Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:13 AM
Ignite Modification Date:
2025-12-26 @ 3:11 AM
NCT ID:
NCT02397720
Group ID:
EG003
Title:
Arm 2 B (Azacitidine, Nivolumab, Ipilimumab)
Description:
Patients receive azacitidine and nivolumab as Arm I. Patients also receive ipilimumab IV over 90 minutes on day 1 and then every 6 or 12 weeks. Treatment continues in the absence of disease progression or unacceptable toxicity.
Azacitidine: Given SC or IV
Ipilimumab
Nivolumab: Given IV
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
33
Serious Number At Risk:
47
Other Number Affected:
25
Other Number At Risk:
47
Study:
NCT02397720
Results Section:
NCT02397720
Adverse Events Module:
NCT02397720